Authors
Latest:
Complement Inhibition in Myasthenia GravisRecent advancements have the potential to significantly improve the lives of individuals with myasthenia gravis and contribute to the broader understanding of autoimmune diseases
Latest:
Richard Finkel, MD: Goals of St. Jude Center for Experimental NeurotherapeuticsThe newly appointed director for the Center for Experimental Neurotherapeutics at St. Jude Children’s Research Hospital details his personal responsibilities and the long-term goals for the new center.
Latest:
Advocacy in Neurology: A Tool to Serve and Find FulfillmentActing as an advocate is meaningful to neurologists because it speaks to their inner core—or their “why.” Neurologists have the agency to make this world a better place while working as a neurologist and an advocate at many levels.
Latest:
Rolf Fronczek, PhD, MD: Cluster Headaches and SleepRecent work demonstrates that the anterior part of the hypothalamus is enlarged in cluster headache.
Latest:
Noah Rosen, MD: Evaluation of Cardiovascular Risks of Galcanezumab in Episodic, Chronic MigraineThe program director of neurology at the Zucker School of Medicine, Northwell Health, spoke about the great advances of the new CGRP medications available for the prevention of migraine.
Latest:
Analyzing Long-Term, End-Of-Study Results for Inebilizumab Treatment in NMOSD: Bruce Cree, MD, PhD, MAS, FAANThe clinical research director of the UCSF Multiple Sclerosis Center discussed findings from the end-of-study analysis assessing inebilizumab which revealed a significant reduction in attack rates among patients with NMOSD over time. [WATCH TIME: 3 minutes]
Latest:
Cyclic Vomiting, Incontinence in a Young BoyAn 8 year old boy with genetically confirmed neurofibromatosis type 1 presents with first generalized seizure.
Latest:
Building Trust in the Epilepsy Clinician-Patient Relationship: Elizabeth Felton, MD, PhDThe assistant professor in the Department of Neurology at the University of Wisconsin spoke about healthcare providers establishing trust with their patients and improving health equity. [WATCH TIME: 3 minutes]
Latest:
Daniel Lowenstein, MD: Understanding the Gut-Brain Connection in EpilepsyThe professor of neurology and executive vice chancellor and provost at the University of California, San Francisco detailed the connection between the gut microbiome and epilepsy.
Latest:
Dystrophin Pathway and Treatments Offer Hope for Patients with Duchenne Muscular DystrophyGene therapy has generated excitement as a treatment or even a potential cure for inherited diseases. Among them: Duchenne muscular dystrophy.
Latest:
Jacksonian Epilepsy and the Jacksonian March: R. Edward Hogan, MDThe professor of neurology at Washington University in St. Louis, and the president of the American Epilepsy Society, shared his perspective on John Hughlings Jackson’s observations of epilepsy in the brain and how it can inform modern practice. [WATCH TIME: 5 minutes]
Latest:
Expanding the Knowledge Profile and Treatment Capabilities of Lecanemab: Lynn Kramer, MD, FAANThe chief medical officer at Eisai provided context towards the ongoing initiatives to further the efficacy and safety profile of lecanemab, an FDA-approved treatment for early Alzheimer disease. [WATCH TIME: 3 minutes]
Latest:
ISC Post-Conference Recap: What Other Early Career Attendees Should KnowThird year neurology resident Mona Al Banna, MB BCh BAO, MSc(Res) recounts her first major medical conference experience and provides guidance on how to make the most of your attendance, especially as a resident or fellow.
Latest:
Monoclonal Antibodies for Alzheimer Disease and Lecanemab’s Potential: Richard Isaacson, MDThe director of the Center for Brain Health and Alzheimer prevention clinic at FAU medicine shares his experience during the Medical Crossfire session on the Alheimer pipeline that he took part in at the fourth annual International Congress on the Future of Neurology. [WATCH TIME: 7 minutes]
Latest:
Emily Splichal, DPM: Using Texture for Nerve Stimulation in the FeetMany patients with neurologic conditions such as multiple sclerosis are faced with gait and stability issues due to their disease, but Splichal and Naboso Technology seek to address these issues via mechanoreceptor stimulation.
Latest:
The Debate About Hormone Replacement Therapy During Menopause in MS: Rhonda R. Voskuhl, MDThe director of the Multiple Sclerosis Program at UCLA discussed the need to consider HRT among women with MS going through menopause, and how HRT can improve its negative effects. [WATCH TIME: 4 minutes]
Latest:
George Koshy Vilanilam, MBBS: Migraine as a Risk Factor for Ischemic StrokeThe study found that there has been a significant increasing trend in patients with migraine—irrespective of aura status—having an ischemic stroke.
Latest:
Elizabeth Ross, MD, PhD: Improving the Field By Understanding MechanismsThe director of the Center of Neurogenetics at Weill Cornell Medicine spoke about the wealth of improvements that have really turned this area of medicine into a much more hopeful one.
Latest:
John Didsbury, PhD: Going Against the Grain in Established AlzheimerThe founder and CEO of T3D Therapeutics, Inc., spoke about T3D’s desire to go against the grain and trend in the therapeutic development for mild to moderate Alzheimer disease.
Latest:
Jeremy Payne, MD, PhD: The Lack of Progress for TelestrokeThe director of the Stroke Center at Banner-University Medicine Neuroscience Institute spoke to the need for data like that from the TELECAST study and how the COVID-19 pandemic might push telestroke care forward.
Latest:
Nir Lipsman, MD, PhD: Innovations in Alzheimer DiseaseThe neurosurgeon from Sunnybrook Health Sciences Centre spoke about his excitement about where the medical community is at, at this point, in the understanding of Alzheimer disease.
Latest:
Future Treatment of hATTR AmyloidosisAnalysis of current and newer therapies for the treatment of hereditary ATTR amyloidosis.
Latest:
Joseph Berger, MD: The Role of Artificial Intelligence in NeurologyThe associate chief of the MS division and professor of neurology at Penn Medicine described the ongoing relationship between artificial intelligence and neurologists, and how it may evolve in the future.
Latest:
Differences in Effective Therapies for Pediatric versus Adults with MS: Brenda Banwell, MDThe chief of neurology and codirector of the neuroscience Center at the Children's Hospital of Philadelphia spoke at ECTRIMS 2022 about the difference in conversation for therapies between pediatric patients and adult patients with MS. [WATCH TIME: 5 minutes]
Latest:
FDA Approves Pfizer COVID-19 Vaccine for Those Ages 16 Years and OlderThe full approval for BNT162b2 (Comirnaty; Pfizer/BioNTech) will afford physicians greater prescribing capability and is expected to play a role in driving workplace vaccine mandates.
